5/9/2012 PFE Pfizer Inc. Tofacitinib tablets (NDA) FDA panel to review Tofacitinib for treatment of adult patients with moderately to severely active rheumatoid arthritis
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.